Biotechnology
The Biotechnology industry has a total of 593 stocks, with a combined market cap of $1.35 trillion and total revenue of $115.84 billion.
Market Cap
1.35T
Revenue
115.84B
Profits
-39.64B
PE Ratio
n/a
Profit Margin
-34.23%
Dividend Yield
0.04%
593 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 137.30B | -1.07% | 886,732 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.30B | -1.67% | 488,296 | 15.53B |
| 3 | ARGX | argenx SE | 64.97B | -3.37% | 175,504 | 5.32B |
| 4 | MRNA | Moderna, Inc. | 55.09B | -3.35% | 26,262,386 | 2.23B |
| 5 | RVMD | Revolution Medicines, Inc. | 44.56B | -6.00% | 2,005,966 | - |
| 6 | ONC | BeOne Medicines AG | 41.70B | -1.55% | 341,579 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 34.99B | -1.73% | 1,701,638 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.73B | 0.23% | 1,847,136 | 4.80B |
| 9 | INSM | Insmed Incorporated | 25.89B | -2.35% | 1,977,807 | 1.14B |
| 10 | BNTX | BioNTech SE | 25.64B | -8.37% | 3,170,849 | 3.03B |
| 11 | INCY | Incyte Corporation | 25.21B | -2.64% | 1,214,994 | 5.82B |
| 12 | ROIV | Roivant Sciences Ltd. | 25.07B | -7.64% | 8,764,828 | 7.53M |
| 13 | GMAB | Genmab A/S | 19.98B | -2.55% | 1,518,709 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 16.28B | -0.58% | 314,720 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.87B | -2.61% | 1,207,371 | 4.60B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.97B | -2.64% | 1,957,845 | 713.07M |
| 17 | EXEL | Exelixis, Inc. | 13.49B | -1.47% | 1,486,614 | 2.44B |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 12.52B | -0.96% | 1,098,405 | 3.41B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.33B | -1.83% | 268,663 | 1.28B |
| 20 | CORT | Corcept Therapeutics Incorporated | 12.31B | -2.61% | 917,878 | 830.81M |
| 21 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.99B | -4.15% | 1,281,990 | 669.50M |
| 22 | HALO | Halozyme Therapeutics, Inc. | 11.96B | -1.47% | 1,681,503 | 1.66B |
| 23 | TECH | Bio-Techne Corporation | 11.35B | -0.17% | 1,630,485 | 1.22B |
| 24 | SMMT | Summit Therapeutics Inc. | 10.95B | -4.19% | 3,906,883 | - |
| 25 | ABVX | ABIVAX Société Anonyme | 10.58B | -0.83% | 926,190 | 5.67M |
| 26 | AXSM | Axsome Therapeutics, Inc. | 10.42B | -3.51% | 441,304 | 776.57M |
| 27 | KRYS | Krystal Biotech, Inc. | 10.40B | -1.68% | 143,504 | 440.48M |
| 28 | APGE | Apogee Therapeutics, Inc. | 10.18B | 0.01% | 733,855 | - |
| 29 | IONS | Ionis Pharmaceuticals, Inc. | 10.15B | -2.21% | 1,850,851 | 874.09M |
| 30 | CYTK | Cytokinetics, Incorporated | 10.02B | -7.46% | 4,358,592 | 67.67M |
| 31 | KYMR | Kymera Therapeutics, Inc. | 9.82B | -1.73% | 415,926 | 105.00M |
| 32 | PRAX | Praxis Precision Medicines, Inc. | 9.63B | -6.28% | 282,846 | 7.46M |
| 33 | PTGX | Protagonist Therapeutics, Inc. | 9.34B | -3.46% | 501,194 | 281.99M |
| 34 | CRNX | Crinetics Pharmaceuticals, Inc. | 9.00B | -0.01% | 1,127,258 | 42.16M |
| 35 | PCVX | Vaxcyte, Inc. | 8.90B | -2.17% | 759,888 | - |
| 36 | IBRX | ImmunityBio, Inc. | 8.53B | -4.17% | 7,980,048 | 165.79M |
| 37 | IMVT | Immunovant, Inc. | 8.51B | -5.98% | 1,082,532 | - |
| 38 | SYRE | Spyre Therapeutics, Inc. | 7.97B | -3.48% | 1,266,540 | - |
| 39 | TGTX | TG Therapeutics, Inc. | 7.65B | -3.21% | 1,030,711 | 799.54M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.38B | -4.76% | 441,208 | 239.92M |
| 41 | CAI | Caris Life Sciences, Inc. | 7.24B | -2.84% | 3,835,175 | 989.61M |
| 42 | SRRK | Scholar Rock Holding Corporation | 7.04B | -2.46% | 809,720 | - |
| 43 | CGON | CG Oncology, Inc. | 6.59B | -5.91% | 612,500 | 6.23M |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 6.33B | -2.30% | 426,506 | 618.07M |
| 45 | ERAS | Erasca, Inc. | 6.31B | -7.49% | 2,886,264 | - |
| 46 | TVTX | Travere Therapeutics, Inc. | 6.19B | -2.74% | 808,480 | 591.33M |
| 47 | BLTE | Belite Bio, Inc | 6.11B | -3.37% | 171,256 | - |
| 48 | ORKA | Oruka Therapeutics, Inc. | 6.03B | -5.59% | 589,407 | - |
| 49 | COGT | Cogent Biosciences, Inc. | 6.02B | -6.52% | 1,771,202 | - |
| 50 | DNTH | Dianthus Therapeutics, Inc. | 5.92B | -5.11% | 376,225 | 1.90M |
| 51 | PTCT | PTC Therapeutics, Inc. | 5.85B | -2.40% | 692,673 | 1.01B |
| 52 | XENE | Xenon Pharmaceuticals Inc. | 5.81B | -3.13% | 587,875 | 7.50M |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 5.59B | -1.42% | 127,691 | 290.54M |
| 54 | CRSP | CRISPR Therapeutics AG | 5.58B | -2.78% | 1,387,603 | 13.39M |
| 55 | DFTX | Definium Therapeutics, Inc. | 5.51B | -6.48% | 1,803,107 | - |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 5.02B | -2.09% | 1,529,971 | 1.14B |
| 57 | PBLS | Parabilis Medicines, Inc. | 4.83B | -0.46% | 316,225 | 148.00K |
| 58 | DYN | Dyne Therapeutics, Inc. | 4.68B | -3.91% | 1,186,929 | - |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 4.64B | -3.24% | 739,627 | - |
| 60 | CELC | Celcuity Inc. | 4.33B | -5.15% | 676,684 | - |
| 61 | ELVN | Enliven Therapeutics, Inc. | 4.24B | -4.36% | 584,838 | - |
| 62 | RLAY | Relay Therapeutics, Inc. | 4.11B | -3.35% | 2,762,902 | 10.35M |
| 63 | MANE | Veradermics, Incorporated | 4.09B | -3.81% | 623,539 | - |
| 64 | TNGX | Tango Therapeutics, Inc. | 3.94B | -7.67% | 1,998,852 | 53.81M |
| 65 | IDYA | IDEAYA Biosciences, Inc. | 3.87B | -3.97% | 714,064 | 234.13M |
| 66 | LEGN | Legend Biotech Corporation | 3.85B | -3.02% | 1,151,059 | 1.27B |
| 67 | DNLI | Denali Therapeutics Inc. | 3.84B | -2.72% | 807,548 | 3.60M |
| 68 | TLX | Telix Pharmaceuticals Limited | 3.82B | -0.75% | 84,839 | 890.79M |
| 69 | VKTX | Viking Therapeutics, Inc. | 3.75B | -5.02% | 2,379,722 | - |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.72B | -4.51% | 1,086,192 | 117.00M |
| 71 | ABCL | AbCellera Biologics Inc. | 3.68B | -8.47% | 5,861,231 | 66.17M |
| 72 | IOVA | Iovance Biotherapeutics, Inc. | 3.63B | -3.03% | 7,693,530 | 324.97M |
| 73 | QURE | uniQure N.V. | 3.38B | -1.69% | 843,660 | 18.67M |
| 74 | GPCR | Structure Therapeutics Inc. | 3.38B | -3.76% | 601,744 | - |
| 75 | TARS | Tarsus Pharmaceuticals, Inc. | 3.15B | -0.22% | 615,723 | 606.33M |
| 76 | IMNM | Immunome, Inc. | 3.13B | -4.50% | 784,509 | 4.02M |
| 77 | NAMS | NewAmsterdam Pharma Company N.V. | 3.10B | -3.32% | 1,036,085 | 7.12M |
| 78 | IRON | Disc Medicine, Inc. | 3.07B | -3.05% | 665,565 | - |
| 79 | CLDX | Celldex Therapeutics, Inc. | 3.07B | -3.31% | 424,938 | 158.00K |
| 80 | MBX | MBX Biosciences, Inc. | 3.03B | -5.11% | 307,545 | - |
| 81 | ARQT | Arcutis Biotherapeutics, Inc. | 2.99B | -4.38% | 1,535,819 | 463.98M |
| 82 | BEAM | Beam Therapeutics Inc. | 2.93B | -3.81% | 1,330,486 | 156.04M |
| 83 | ZLAB | Zai Lab Limited | 2.93B | -2.76% | 650,029 | 449.61M |
| 84 | ALMS | Alumis Inc. | 2.90B | -3.58% | 655,332 | 7.40M |
| 85 | NRIX | Nurix Therapeutics, Inc. | 2.72B | -2.49% | 929,192 | 36.77M |
| 86 | ATAI | AtaiBeckley Inc. | 2.70B | -0.82% | 2,532,060 | 4.47M |
| 87 | SLS | SELLAS Life Sciences Group, Inc. | 2.67B | -13.15% | 9,825,336 | - |
| 88 | VRDN | Viridian Therapeutics, Inc. | 2.61B | -3.35% | 778,838 | 71.13M |
| 89 | RARE | Ultragenyx Pharmaceutical Inc. | 2.52B | -2.48% | 1,612,866 | 717.00M |
| 90 | PGEN | Precigen, Inc. | 2.49B | -3.34% | 2,703,231 | 85.72M |
| 91 | PHVS | Pharvaris N.V. | 2.48B | -4.54% | 479,029 | - |
| 92 | NKTR | Nektar Therapeutics | 2.48B | -2.72% | 579,514 | 54.59M |
| 93 | VERA | Vera Therapeutics, Inc. | 2.46B | -1.18% | 1,257,469 | - |
| 94 | TRVI | Trevi Therapeutics, Inc. | 2.39B | -6.51% | 1,972,139 | - |
| 95 | KOD | Kodiak Sciences Inc. | 2.37B | -3.58% | 469,174 | - |
| 96 | RAPP | Rapport Therapeutics, Inc. | 2.34B | -4.05% | 332,725 | 20.00M |
| 97 | NUVB | Nuvation Bio Inc. | 2.34B | -4.72% | 3,662,045 | 169.90M |
| 98 | BHVN | Biohaven Ltd. | 2.33B | -4.40% | 2,887,982 | - |
| 99 | MESO | Mesoblast Limited | 2.29B | -4.07% | 234,739 | 120.25M |
| 100 | HRMY | Harmony Biosciences Holdings, Inc. | 2.28B | -1.66% | 590,203 | 959.90M |
| 101 | OCUL | Ocular Therapeutix, Inc. | 2.28B | -4.25% | 1,563,596 | 52.06M |
| 102 | MLYS | Mineralys Therapeutics, Inc. | 2.26B | -1.58% | 812,833 | - |
| 103 | SRPT | Sarepta Therapeutics, Inc. | 2.20B | -3.38% | 3,612,129 | 1.97B |
| 104 | AUPH | Aurinia Pharmaceuticals Inc. | 2.17B | -1.15% | 630,878 | 311.51M |
| 105 | PVLA | Palvella Therapeutics, Inc. | 2.16B | -0.24% | 191,822 | - |
| 106 | NBTX | Nanobiotix S.A. | 2.13B | -8.70% | 164,842 | 38.27M |
| 107 | URGN | UroGen Pharma Ltd. | 2.13B | -4.13% | 580,050 | 188.73M |
| 108 | KLRA | Kailera Therapeutics, Inc. | 2.10B | -12.52% | 531,809 | - |
| 109 | VCEL | Vericel Corporation | 2.10B | -0.56% | 491,245 | 306.30M |
| 110 | COAG | Hemab Therapeutics Holdings, Inc. | 2.09B | -9.40% | 259,973 | - |
| 111 | ADMA | ADMA Biologics, Inc. | 2.09B | -1.48% | 1,838,106 | 512.28M |
| 112 | STOK | Stoke Therapeutics, Inc. | 2.04B | -2.98% | 754,092 | 27.59M |
| 113 | ZBIO | Zenas BioPharma, Inc. | 2.04B | -4.14% | 439,124 | 1.00M |
| 114 | ZYME | Zymeworks Inc. | 2.01B | -2.55% | 542,057 | 37.13M |
| 115 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.99B | -8.24% | 5,564,528 | 208.78M |
| 116 | AGIO | Agios Pharmaceuticals, Inc. | 1.99B | -2.80% | 519,739 | 98.34M |
| 117 | GENB | Generate Biomedicines, Inc. | 1.97B | -2.79% | 2,354,944 | 26.48M |
| 118 | FBRX | Forte Biosciences, Inc. | 1.94B | - | - | - |
| 119 | XNCR | Xencor, Inc. | 1.94B | -9.76% | 2,051,637 | 104.97M |
| 120 | GHRS | GH Research PLC | 1.92B | -2.48% | 117,626 | - |
| 121 | LKFT | Lakefront Biotherapeutics NV | 1.89B | -2.38% | 143,741 | 1.13B |
| 122 | IMCR | Immunocore Holdings plc | 1.89B | -0.35% | 300,325 | 430.78M |
| 123 | TSHA | Taysha Gene Therapies, Inc. | 1.88B | -3.19% | 2,070,833 | 5.49M |
| 124 | KARD | Kardigan, Inc. | 1.87B | -3.75% | 196,555 | - |
| 125 | VIR | Vir Biotechnology, Inc. | 1.83B | -4.24% | 1,835,139 | 303.23M |
| 126 | INBX | Inhibrx Biosciences, Inc. | 1.82B | -0.06% | 241,479 | 1.30M |
| 127 | SEPN | Septerna, Inc. | 1.82B | -3.85% | 385,854 | 98.88M |
| 128 | NTLA | Intellia Therapeutics, Inc. | 1.80B | -1.83% | 3,441,960 | 59.51M |
| 129 | RXRX | Recursion Pharmaceuticals, Inc. | 1.79B | -2.91% | 10,560,396 | 54.86M |
| 130 | DMRA | Damora Therapeutics, Inc. | 1.79B | -5.23% | 371,723 | - |
| 131 | FTRE | Fortrea Holdings Inc. | 1.79B | -0.27% | 1,140,969 | 2.68B |
| 132 | BRVE | Braveheart Bio, Inc. | 1.76B | -1.51% | 162,456 | - |
| 133 | SNDX | Syndax Pharmaceuticals, Inc. | 1.74B | -3.08% | 1,042,612 | 252.25M |
| 134 | ANAB | AnaptysBio, Inc. | 1.67B | -1.76% | 358,262 | 232.39M |
| 135 | APMD | Apnimed, Inc. | 1.65B | 3.45% | 536,837 | 120.15M |
| 136 | AAPG | Ascentage Pharma Group International | 1.64B | -2.42% | 6,355 | 94.61M |
| 137 | BCAX | Bicara Therapeutics Inc. | 1.55B | -5.64% | 524,734 | - |
| 138 | LBRX | LB Pharmaceuticals Inc | 1.54B | -0.33% | 230,557 | - |
| 139 | SLBT | SL Science Holding Limited | 1.54B | 2.27% | 40,916 | 3.27M |
| 140 | AVLN | Avalyn Pharma Inc. | 1.54B | -4.98% | 202,893 | - |
| 141 | LTGO | Latigo Biotherapeutics, Inc. | 1.53B | -3.08% | 217,740 | - |
| 142 | NVAX | Novavax, Inc. | 1.53B | 2.32% | 4,211,659 | 413.80M |
| 143 | MAZE | Maze Therapeutics, Inc. | 1.52B | -4.06% | 250,248 | 20.00M |
| 144 | INVA | Innoviva, Inc. | 1.51B | 0.05% | 527,008 | 440.00M |
| 145 | TRAX | First Tracks Biotherapeutics, Inc. | 1.50B | -6.44% | 409,886 | - |
| 146 | ABSI | Absci Corporation | 1.49B | -7.54% | 2,507,264 | 1.56M |
| 147 | TYRA | Tyra Biosciences, Inc. | 1.49B | -4.55% | 217,472 | - |
| 148 | AVBP | ArriVent BioPharma, Inc. | 1.49B | -2.68% | 353,458 | - |
| 149 | REPL | Replimune Group, Inc. | 1.46B | -0.64% | 2,386,710 | - |
| 150 | AKTS | Aktis Oncology, Inc. | 1.43B | -1.53% | 314,633 | 10.06M |
| 151 | CGEM | Cullinan Therapeutics, Inc. | 1.40B | -3.98% | 629,994 | - |
| 152 | ANRO | Alto Neuroscience, Inc. | 1.38B | -3.22% | 246,716 | - |
| 153 | ORIC | ORIC Pharmaceuticals, Inc. | 1.37B | -3.64% | 765,307 | - |
| 154 | DRTS | Alpha Tau Medical Ltd. | 1.35B | -1.15% | 475,218 | - |
| 155 | OMER | Omeros Corporation | 1.35B | -3.32% | 1,144,026 | 38.42M |
| 156 | VOR | Vor Biopharma Inc. | 1.34B | -3.74% | 491,044 | - |
| 157 | SVRA | Savara Inc. | 1.34B | -4.19% | 1,336,279 | - |
| 158 | MGTX | MeiraGTx Holdings plc | 1.33B | -2.26% | 913,919 | 397.50M |
| 159 | JBIO | Jade Biosciences, Inc. | 1.33B | -2.11% | 357,914 | - |
| 160 | IMTX | Immatics N.V. | 1.29B | 0.96% | 1,094,104 | 47.65M |
| 161 | SPTX | Seaport Therapeutics, Inc. | 1.29B | -8.42% | 144,823 | - |
| 162 | MLTX | MoonLake Immunotherapeutics | 1.28B | -3.48% | 700,384 | - |
| 163 | MNKD | MannKind Corporation | 1.27B | -2.71% | 1,990,111 | 393.63M |
| 164 | CRVS | Corvus Pharmaceuticals, Inc. | 1.19B | -3.80% | 644,234 | - |
| 165 | SANA | Sana Biotechnology, Inc. | 1.18B | -3.91% | 2,143,892 | - |
| 166 | ODTX | Odyssey Therapeutics, Inc. | 1.17B | -6.24% | 117,278 | 99.00K |
| 167 | GLUE | Monte Rosa Therapeutics, Inc. | 1.14B | -6.56% | 884,529 | 28.73M |
| 168 | KURA | Kura Oncology, Inc. | 1.13B | -3.95% | 1,811,826 | 77.23M |
| 169 | JANX | Janux Therapeutics, Inc. | 1.10B | -3.99% | 637,806 | 24.00M |
| 170 | IVA | Inventiva S.A. | 1.10B | -3.98% | 1,124,657 | 7.94M |
| 171 | AVTX | Avalo Therapeutics, Inc. | 1.05B | -2.29% | 738,274 | 59.00K |
| 172 | SLDB | Solid Biosciences Inc. | 1.05B | -3.55% | 621,509 | - |
| 173 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.02B | -1.29% | 2,679,212 | 41.47M |
| 174 | ABUS | Arbutus Biopharma Corporation | 1.00B | -1.93% | 4,768,943 | 181.72M |
| 175 | CADL | Candel Therapeutics, Inc. | 1.00B | -4.95% | 1,236,453 | - |
| 176 | IMMX | Immix Biopharma, Inc. | 997.26M | -2.59% | 1,143,437 | - |
| 177 | WVE | Wave Life Sciences, Inc. | 993.12M | -2.33% | 2,250,701 | 65.37M |
| 178 | GERN | Geron Corporation | 970.13M | -1.31% | 7,416,982 | 204.56M |
| 179 | ARDX | Ardelyx, Inc. | 949.40M | -0.26% | 5,133,514 | 450.89M |
| 180 | DSGN | Design Therapeutics, Inc. | 945.61M | -0.92% | 820,453 | - |
| 181 | ANNX | Annexon, Inc. | 942.21M | -5.33% | 1,618,492 | - |
| 182 | OLMA | Olema Pharmaceuticals, Inc. | 898.60M | -4.82% | 740,849 | - |
| 183 | ATTO | Attovia Therapeutics, Inc. | 890.70M | -3.54% | 127,603 | 1.35M |
| 184 | ANL | Adlai Nortye Group Ltd. | 889.98M | -3.49% | 165,026 | 18.06M |
| 185 | HELP | Cybin Inc. | 889.87M | -8.01% | 1,455,254 | - |
| 186 | TBPH | Theravance Biopharma, Inc. | 885.21M | 0.06% | 414,568 | 104.31M |
| 187 | ACRS | Aclaris Therapeutics, Inc. | 884.67M | -2.44% | 1,220,839 | 8.22M |
| 188 | SGP | SpyGlass Pharma, Inc. | 883.70M | -1.89% | 89,780 | - |
| 189 | FTH | Faeth Therapeutics, Inc. | 874.44M | 0.30% | 288,293 | - |
| 190 | RIGL | Rigel Pharmaceuticals, Inc. | 868.24M | -0.81% | 246,110 | 276.79M |
| 191 | CLYM | Climb Bio, Inc. | 836.85M | -3.25% | 840,929 | - |
| 192 | ACHV | Achieve Life Sciences, Inc. | 833.51M | -0.98% | 988,989 | - |
| 193 | PHAR | Pharming Group N.V. | 816.45M | -0.68% | 9,446 | 366.48M |
| 194 | DBVT | DBV Technologies S.A. | 815.25M | -6.04% | 145,994 | 5.04M |
| 195 | FDMT | 4D Molecular Therapeutics, Inc. | 810.43M | -1.61% | 1,101,306 | 92.01M |
| 196 | SLN | Silence Therapeutics plc | 808.01M | -0.22% | 539,702 | 615.00K |
| 197 | NVCT | Nuvectis Pharma, Inc. | 773.16M | -5.80% | 137,187 | - |
| 198 | AURA | Aura Biosciences, Inc. | 767.42M | -3.90% | 441,402 | - |
| 199 | CBIO | Crescent Biopharma, Inc. | 759.72M | -0.06% | 149,147 | 11.88M |
| 200 | OCS | Oculis Holding AG | 753.75M | -1.77% | 221,848 | 1.45M |
| 201 | MNPR | Monopar Therapeutics Inc. | 751.02M | -1.80% | 221,544 | - |
| 202 | NGNE | Neurogene Inc. | 732.02M | -3.38% | 132,795 | 925.00K |
| 203 | PHAT | Phathom Pharmaceuticals, Inc. | 729.17M | 2.68% | 894,401 | 239.66M |
| 204 | DRUG | Bright Minds Biosciences Inc. | 721.39M | -2.32% | 107,334 | - |
| 205 | STTK | Shattuck Labs, Inc. | 706.56M | -7.97% | 623,097 | 1.00M |
| 206 | OBX | Obsidian Therapeutics, Inc. | 706.22M | -4.34% | 260,517 | - |
| 207 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 700.72M | -4.79% | 195,025 | - |
| 208 | MPLT | MapLight Therapeutics, Inc. | 700.25M | 0.48% | 375,074 | - |
| 209 | CTMX | CytomX Therapeutics, Inc. | 699.46M | -6.14% | 2,173,799 | 18.30M |
| 210 | GYRE | Gyre Therapeutics, Inc. | 698.76M | -1.35% | 43,160 | 109.82M |
| 211 | ALLO | Allogene Therapeutics, Inc. | 697.89M | -3.35% | 3,824,689 | 4.64M |
| 212 | TECX | Tectonic Therapeutic, Inc. | 696.35M | -2.94% | 157,790 | - |
| 213 | ASMB | Assembly Biosciences, Inc. | 693.69M | -2.10% | 250,017 | 74.85M |
| 214 | ZVRA | Zevra Therapeutics, Inc. | 686.77M | -2.41% | 617,839 | 136.07M |
| 215 | MDXG | MiMedx Group, Inc. | 655.92M | -0.22% | 887,014 | 355.17M |
| 216 | SGMT | Sagimet Biosciences Inc. | 655.77M | -1.86% | 573,990 | - |
| 217 | VSTM | Verastem, Inc. | 653.87M | -2.17% | 1,084,339 | 87.53M |
| 218 | OABI | OmniAb, Inc. | 649.90M | -3.04% | 1,297,189 | 38.46M |
| 219 | AGMB | AgomAb Therapeutics NV | 648.60M | -4.84% | 252,919 | - |
| 220 | CRMD | CorMedix Inc. | 646.94M | -0.12% | 780,215 | 462.25M |
| 221 | PRME | Prime Medicine, Inc. | 642.23M | -0.82% | 2,694,334 | 4.07M |
| 222 | CTNM | Contineum Therapeutics, Inc. | 641.44M | -1.16% | 477,838 | - |
| 223 | RGNX | REGENXBIO Inc. | 637.69M | 3.09% | 1,754,144 | 174.48M |
| 224 | AUTL | Autolus Therapeutics plc | 622.82M | -0.85% | 1,436,862 | 117.39M |
| 225 | VALN | Valneva SE | 615.36M | -1.98% | 22,286 | 163.30M |
| 226 | ALT | Altimmune, Inc. | 604.95M | -4.01% | 3,193,611 | 31.00K |
| 227 | ARVN | Arvinas, Inc. | 600.25M | -0.65% | 600,337 | 316.70M |
| 228 | BLSM | BlossomHill Therapeutics, Inc. | 599.39M | -1.21% | 163,528 | - |
| 229 | EIKN | Eikon Therapeutics, Inc. | 594.73M | -4.69% | 239,636 | - |
| 230 | SPRY | ARS Pharmaceuticals, Inc. | 585.74M | -2.32% | 1,190,262 | 116.93M |
| 231 | PRLD | Prelude Therapeutics Incorporated | 563.38M | -13.72% | 725,232 | 22.42M |
| 232 | CAPR | Capricor Therapeutics, Inc. | 557.55M | -4.67% | 5,186,466 | 11.13M |
| 233 | PROK | ProKidney Corp. | 553.25M | 0.55% | 1,128,942 | 818.00K |
| 234 | ZURA | Zura Bio Limited | 548.14M | -2.22% | 1,893,428 | - |
| 235 | OVID | Ovid Therapeutics Inc. | 546.83M | -4.44% | 1,673,900 | 1.58M |
| 236 | ARTV | Artiva Biotherapeutics, Inc. | 542.19M | -7.12% | 223,492 | 251.00K |
| 237 | SCTX | Scribe Therapeutics Inc. | 536.50M | -1.39% | 201,597 | 36.28M |
| 238 | CABA | Cabaletta Bio, Inc. | 528.98M | -7.69% | 3,239,397 | - |
| 239 | ENTX | Entera Bio Ltd. | 524.62M | -1.62% | 137,938 | 42.00K |
| 240 | KYTX | Kyverna Therapeutics, Inc. | 517.63M | -3.13% | 524,689 | - |
| 241 | EDIT | Editas Medicine, Inc. | 485.31M | -4.24% | 3,271,503 | 47.01M |
| 242 | RZLT | Rezolute, Inc. | 482.64M | -7.23% | 1,084,294 | - |
| 243 | EVMN | Evommune, Inc. | 480.14M | -1.85% | 350,567 | 10.00M |
| 244 | PRTA | Prothena Corporation plc | 478.97M | 2.64% | 498,115 | 54.53M |
| 245 | CCCC | C4 Therapeutics, Inc. | 473.65M | -6.10% | 1,828,731 | 35.04M |
| 246 | VOGX | Vogenx, Inc. | 472.64M | 0.98% | 38,132 | - |
| 247 | DNA | Ginkgo Bioworks Holdings, Inc. | 468.69M | -4.13% | 1,263,558 | 132.42M |
| 248 | PBYI | Puma Biotechnology, Inc. | 467.68M | -1.95% | 235,034 | 231.24M |
| 249 | RLMD | Relmada Therapeutics, Inc. | 461.88M | -4.20% | 678,358 | - |
| 250 | OCGN | Ocugen, Inc. | 447.63M | -3.65% | 3,100,322 | 4.58M |
| 251 | QTTB | Q32 Bio Inc. | 447.44M | -6.93% | 353,914 | 53.74M |
| 252 | EPRX | Eupraxia Pharmaceuticals Inc. | 440.21M | -9.31% | 174,227 | - |
| 253 | IKT | Inhibikase Therapeutics, Inc. | 438.80M | -2.43% | 307,938 | 1.00 |
| 254 | CMPX | Compass Therapeutics, Inc. | 432.21M | -4.76% | 2,567,637 | 850.00K |
| 255 | ARCT | Arcturus Therapeutics Holdings Inc. | 431.75M | -6.06% | 1,619,519 | 29.37M |
| 256 | FENC | Fennec Pharmaceuticals Inc. | 430.27M | 4.25% | 421,787 | 59.22M |
| 257 | AVIR | Atea Pharmaceuticals, Inc. | 429.90M | -1.65% | 144,614 | - |
| 258 | BNTC | Benitec Biopharma Inc. | 428.40M | -1.58% | 103,166 | - |
| 259 | RCKT | Rocket Pharmaceuticals, Inc. | 423.73M | 6.63% | 3,454,755 | - |
| 260 | LRMR | Larimar Therapeutics, Inc. | 418.58M | -0.99% | 641,470 | - |
| 261 | GALT | Galectin Therapeutics Inc. | 405.42M | -2.90% | 271,100 | - |
| 262 | VTVT | vTv Therapeutics Inc. | 402.07M | -1.34% | 90,241 | 36.84M |
| 263 | XFOR | X4 Pharmaceuticals, Inc. | 400.55M | -4.49% | 356,154 | 15.85M |
| 264 | LXEO | Lexeo Therapeutics, Inc. | 398.73M | -2.61% | 663,603 | - |
| 265 | ENTA | Enanta Pharmaceuticals, Inc. | 396.11M | -1.45% | 154,776 | 65.26M |
| 266 | EYPT | EyePoint, Inc. | 386.23M | -3.24% | 4,393,543 | 2.79M |
| 267 | IPSC | Century Therapeutics, Inc. | 366.68M | -9.19% | 630,546 | 109.16M |
| 268 | UPB | Upstream Bio, Inc. | 366.42M | -1.47% | 445,475 | 3.16M |
| 269 | ZNTL | Zentalis Pharmaceuticals, Inc. | 359.75M | -2.06% | 695,394 | 26.87M |
| 270 | FHTX | Foghorn Therapeutics Inc. | 356.31M | -3.54% | 370,692 | 36.74M |
| 271 | LYEL | Lyell Immunopharma, Inc. | 356.06M | -0.55% | 78,121 | 27.00K |
| 272 | PALI | Palisade Bio, Inc. | 348.54M | -5.21% | 2,127,332 | 500.00K |
| 273 | AGEN | Agenus Inc. | 344.86M | -1.92% | 741,082 | 132.69M |
| 274 | SABS | SAB Biotherapeutics, Inc. | 344.84M | -3.56% | 202,595 | 114.70K |
| 275 | DMAC | DiaMedica Therapeutics Inc. | 344.59M | -5.33% | 116,506 | - |
| 276 | STRO | Sutro Biopharma, Inc. | 339.08M | -4.04% | 143,815 | 45.70M |
| 277 | ABEO | Abeona Therapeutics Inc. | 338.53M | -1.99% | 912,886 | 25.52M |
| 278 | YDES | YD Bio Limited | 337.54M | 24.03% | 217,781 | 510.36K |
| 279 | IFRX | InflaRx N.V. | 328.63M | -1.76% | 610,389 | -11.54K |
| 280 | PRQR | ProQR Therapeutics N.V. | 323.17M | -1.29% | 459,370 | 21.05M |
| 281 | IMRX | Immuneering Corporation | 322.84M | -4.22% | 793,868 | - |
| 282 | VNDA | Vanda Pharmaceuticals Inc. | 319.85M | -2.76% | 525,248 | 215.72M |
| 283 | OBIO | Orchestra BioMed Holdings, Inc. | 311.64M | 1.47% | 154,392 | 31.98M |
| 284 | VCRE | Vicore Pharma Holding AB (publ) | 310.74M | 1.53% | 15,867 | 412.09K |
| 285 | IRD | Opus Genetics, Inc. | 306.99M | -4.16% | 823,618 | 9.86M |
| 286 | CUVL | Clinuvel Pharmaceuticals Limited | 306.45M | -9.01% | 51,250 | 65.05M |
| 287 | BCYC | Bicycle Therapeutics plc | 293.97M | -3.00% | 154,684 | 61.21M |
| 288 | FULC | Fulcrum Therapeutics, Inc. | 293.74M | - | 1,890,635 | 80.00M |
| 289 | TTRX | Turn Therapeutics Inc. | 293.11M | -2.67% | 45,326 | - |
| 290 | FATE | Fate Therapeutics, Inc. | 291.16M | -4.33% | 714,904 | 6.49M |
| 291 | RNAC | Cartesian Therapeutics, Inc. | 290.45M | -3.71% | 65,554 | 1.48M |
| 292 | IVVD | Invivyd, Inc. | 284.29M | 7.15% | 3,633,712 | 58.37M |
| 293 | LCTX | Lineage Cell Therapeutics, Inc. | 280.73M | -4.31% | 587,284 | 13.08M |
| 294 | AVXL | Anavex Life Sciences Corp. | 277.09M | -4.47% | 893,386 | - |
| 295 | ALXO | ALX Oncology Holdings Inc. | 276.55M | -2.44% | 639,789 | - |
| 296 | PYXS | Pyxis Oncology, Inc. | 269.41M | -2.71% | 211,989 | 11.04M |
| 297 | SION | Sionna Therapeutics, Inc. | 265.40M | -3.14% | 784,698 | - |
| 298 | SRZN | Surrozen, Inc. | 263.51M | -6.62% | 239,362 | 11.51M |
| 299 | ACIU | AC Immune SA | 263.48M | -2.21% | 105,642 | 21.67M |
| 300 | WHWK | Whitehawk Therapeutics, Inc. | 263.38M | -5.13% | 39,435 | 7.15M |
| 301 | MGNX | MacroGenics, Inc. | 263.08M | 1.23% | 540,916 | 175.14M |
| 302 | ALEC | Alector, Inc. | 261.28M | -2.09% | 542,220 | 13.86M |
| 303 | NMRA | Neumora Therapeutics, Inc. | 261.18M | -6.08% | 696,275 | - |
| 304 | NAGE | Niagen Bioscience, Inc. | 260.87M | 2.49% | 498,282 | 129.08M |
| 305 | CAMP | Camp4 Therapeutics Corporation | 260.43M | 0.24% | 142,055 | 4.22M |
| 306 | ELDN | Eledon Pharmaceuticals, Inc. | 260.29M | -3.61% | 1,014,802 | - |
| 307 | CLLS | Cellectis S.A. | 256.64M | -4.36% | 5,720 | 63.82M |
| 308 | TRDA | Entrada Therapeutics, Inc. | 252.40M | -3.71% | 111,601 | 4.69M |
| 309 | ADAG | Adagene Inc. | 247.09M | -5.64% | 123,015 | 9.29M |
| 310 | CGEN | Compugen Ltd. | 246.28M | -5.80% | 228,794 | 74.00M |
| 311 | NGEN | NervGen Pharma Corp. | 245.15M | -2.36% | 869,170 | - |
| 312 | RNA | Atrium Therapeutics, Inc. | 233.32M | -2.43% | 108,634 | 35.84M |
| 313 | TNXP | Tonix Pharmaceuticals Holding Corp. | 233.08M | 0.22% | 490,503 | 29.10M |
| 314 | NERV | Minerva Neurosciences, Inc. | 231.10M | -5.65% | 136,732 | - |
| 315 | GLSI | Greenwich LifeSciences, Inc. | 230.01M | -16.34% | 371,036 | - |
| 316 | TARA | Protara Therapeutics, Inc. | 226.34M | -4.01% | 399,077 | - |
| 317 | SLGL | Sol-Gel Technologies Ltd. | 225.28M | -5.18% | 147,789 | 1.80M |
| 318 | KROS | Keros Therapeutics, Inc. | 218.69M | -1.78% | 328,256 | 15.01M |
| 319 | VYGR | Voyager Therapeutics, Inc. | 218.13M | 2.31% | 405,970 | 34.46M |
| 320 | CHRS | Coherus Oncology, Inc. | 217.85M | -3.42% | 605,011 | 50.94M |
| 321 | DTIL | Precision BioSciences, Inc. | 214.74M | -7.38% | 222,526 | 45.06M |
| 322 | NBP | NovaBridge Biosciences | 213.44M | -2.65% | 193,607 | - |
| 323 | PEPG | PepGen Inc. | 213.32M | 0.33% | 484,872 | - |
| 324 | ABOS | Acumen Pharmaceuticals, Inc. | 211.17M | -3.63% | 305,767 | - |
| 325 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 211.01M | -1.98% | 584,311 | - |
| 326 | ANTX | AN2 Therapeutics, Inc. | 210.57M | -2.79% | 240,864 | - |
| 327 | IMUX | Immunic, Inc. | 210.12M | -5.52% | 357,930 | - |
| 328 | ORMP | Oramed Pharmaceuticals Inc. | 209.23M | -1.37% | 154,129 | 2.00M |
| 329 | PLX | Protalix BioTherapeutics, Inc. | 204.65M | -2.68% | 144,990 | 80.62M |
| 330 | IPHA | Innate Pharma S.A. | 204.48M | -0.45% | 11,794 | 10.57M |
| 331 | CUE | Cue Biopharma, Inc. | 202.53M | -0.99% | 102,262 | 37.66M |
| 332 | MSLE | Satellos Bioscience Inc. | 200.19M | -9.89% | 18,266 | - |
| 333 | ARMP | Armata Pharmaceuticals, Inc. | 199.67M | -1.10% | 49,709 | 5.54M |
| 334 | ACOG | Alpha Cognition Inc. | 199.49M | -5.95% | 137,190 | 15.26M |
| 335 | NKTX | Nkarta, Inc. | 197.68M | 0.36% | 430,982 | - |
| 336 | KRRO | Korro Bio, Inc. | 190.11M | -2.64% | 67,367 | 2.38M |
| 337 | CNXU | Conexeu Sciences Inc. | 189.18M | 0.43% | 176,822 | - |
| 338 | HUMA | Humacyte, Inc. | 180.60M | -6.15% | 4,921,511 | 2.12M |
| 339 | CNTN | Canton Strategic Holdings, Inc. | 176.89M | -5.53% | 521,643 | 1.50M |
| 340 | MENS | Jyong Biotech Ltd. | 175.93M | 3.04% | 22,344 | - |
| 341 | SPRB | Spruce Biosciences, Inc. | 174.68M | -3.98% | 39,932 | 697.00K |
| 342 | CDXS | Codexis, Inc. | 174.11M | -4.22% | 634,625 | 77.68M |
| 343 | CRBU | Caribou Biosciences, Inc. | 173.68M | -2.41% | 666,561 | 10.04M |
| 344 | MOLN | Molecular Partners AG | 172.10M | -3.28% | 1,535 | 856.30K |
| 345 | MIST | Milestone Pharmaceuticals Inc. | 163.46M | -2.52% | 865,686 | 2.34M |
| 346 | MDWD | MediWound Ltd. | 163.44M | -4.38% | 165,534 | 11.86M |
| 347 | LENZ | LENZ Therapeutics, Inc. | 160.56M | 6.24% | 680,204 | 21.48M |
| 348 | OTLK | Outlook Therapeutics, Inc. | 157.00M | 0.59% | 9,494,972 | -1.16M |
| 349 | KZIA | Kazia Therapeutics Limited | 155.18M | -19.64% | 1,178,975 | 1.27M |
| 350 | TNYA | Tenaya Therapeutics, Inc. | 154.74M | -0.73% | 1,112,529 | 1.34M |
| 351 | NRXP | NRx Pharmaceuticals, Inc. | 153.58M | -1.93% | 695,596 | 3.39M |
| 352 | OKUR | OnKure Therapeutics, Inc. | 153.48M | -1.04% | 432,473 | - |
| 353 | INDP | Indaptus Therapeutics, Inc. | 151.90M | -1.72% | 104,084 | - |
| 354 | EQ | Equillium, Inc. | 151.55M | -2.45% | 232,718 | 4.39M |
| 355 | UNCY | Unicycive Therapeutics, Inc. | 146.66M | -4.27% | 609,229 | - |
| 356 | CNTB | Connect Biopharma Holdings Limited | 140.43M | -2.19% | 340,634 | 2.95M |
| 357 | HURA | TuHURA Biosciences, Inc. | 134.46M | -0.94% | 99,650 | - |
| 358 | INO | Inovio Pharmaceuticals, Inc. | 133.38M | 2.38% | 1,698,812 | 65.34K |
| 359 | TLSA | Tiziana Life Sciences Ltd | 130.60M | -6.48% | 566,413 | - |
| 360 | BDTX | Black Diamond Therapeutics, Inc. | 128.12M | -1.76% | 521,908 | 70.00M |
| 361 | VANI | Vivani Medical, Inc. | 128.09M | 1.43% | 163,026 | - |
| 362 | AARD | Aardvark Therapeutics, Inc. | 126.71M | -12.54% | 142,965 | - |
| 363 | CBUS | Cibus, Inc. | 126.11M | -1.20% | 89,727 | 4.35M |
| 364 | BMEA | Biomea Fusion, Inc. | 125.40M | 2.98% | 1,168,133 | - |
| 365 | PMN | ProMIS Neurosciences, Inc. | 123.62M | -1.47% | 51,472 | - |
| 366 | ENGN | enGene Therapeutics Inc. | 122.26M | -4.45% | 447,087 | - |
| 367 | TENX | Tenax Therapeutics, Inc. | 122.01M | -2.74% | 2,807,598 | - |
| 368 | GNLX | Genelux Corporation | 119.20M | -7.64% | 417,797 | 8.00K |
| 369 | ANIX | Anixa Biosciences, Inc. | 118.40M | -3.33% | 215,010 | - |
| 370 | RANI | Rani Therapeutics Holdings, Inc. | 117.09M | -1.66% | 371,088 | 4.88M |
| 371 | NTHI | NeOnc Technologies Holdings, Inc. | 116.58M | 1.85% | 100,537 | 39.99K |
| 372 | NAUT | Nautilus Biotechnology, Inc. | 112.71M | -2.04% | 489,270 | 190.00K |
| 373 | SEER | Seer, Inc. | 109.64M | -1.49% | 156,086 | 14.22M |
| 374 | ONCY | Oncolytics Biotech Inc. | 109.23M | 0.78% | 674,382 | - |
| 375 | COYA | Coya Therapeutics, Inc. | 107.67M | -5.56% | 153,108 | 8.02M |
| 376 | GUTS | Fractyl Health, Inc. | 104.90M | -11.16% | 2,380,669 | 3.00K |
| 377 | YARW | Yarrow Bioscience, Inc. | 103.60M | -2.63% | 39,179 | - |
| 378 | PYPD | PolyPid Ltd. | 102.98M | -0.98% | 63,719 | - |
| 379 | PLYX | Polaryx Therapeutics, Inc. | 102.68M | -2.37% | 86,308 | - |
| 380 | VRCA | Verrica Pharmaceuticals Inc. | 97.75M | 12.23% | 351,876 | 30.32M |
| 381 | ACET | Adicet Bio, Inc. | 97.52M | 0.55% | 111,229 | - |
| 382 | CGTX | Cognition Therapeutics, Inc. | 97.00M | -3.77% | 347,422 | - |
| 383 | KLRS | Kalaris Therapeutics, Inc. | 95.93M | -1.71% | 52,613 | - |
| 384 | PTHS | Pelthos Therapeutics Inc. | 94.68M | -1.08% | 40,909 | 43.30M |
| 385 | FBIO | Fortress Biotech, Inc. | 92.38M | -1.07% | 309,686 | 68.47M |
| 386 | ATRA | Atara Biotherapeutics, Inc. | 92.35M | -0.54% | 15,343 | 6.19M |
| 387 | ICCC | ImmuCell Corporation | 90.28M | -0.80% | 5,606 | 30.68M |
| 388 | DWTX | Dogwood Therapeutics, Inc. | 90.08M | 14.22% | 135,376 | - |
| 389 | ALDX | Aldeyra Therapeutics, Inc. | 89.58M | -3.57% | 547,971 | - |
| 390 | RLYB | Rallybio Corporation | 89.27M | 0.30% | 5,757 | 646.00K |
| 391 | ACRV | Acrivon Therapeutics, Inc. | 88.28M | -4.19% | 217,919 | - |
| 392 | OKYO | OKYO Pharma Limited | 87.64M | 7.74% | 135,390 | - |
| 393 | GOSS | Gossamer Bio, Inc. | 83.15M | - | 7,920,885 | 53.29M |
| 394 | ATHE | Alterity Therapeutics Limited | 81.36M | -1.10% | 11,729 | 3.69M |
| 395 | MAIA | MAIA Biotechnology, Inc. | 80.90M | -3.62% | 361,261 | - |
| 396 | TELO | Telomir Pharmaceuticals, Inc. | 78.40M | -4.20% | 38,183 | - |
| 397 | CING | Cingulate Inc. | 77.44M | -2.11% | 108,923 | - |
| 398 | GANX | Gain Therapeutics, Inc. | 77.25M | -4.32% | 312,334 | - |
| 399 | OSTX | OS Therapies Incorporated | 75.65M | -2.38% | 294,984 | - |
| 400 | RNXT | RenovoRx, Inc. | 75.37M | 12.84% | 1,054,849 | 1.98M |
| 401 | NRXS | NeurAxis, Inc. | 75.35M | -0.33% | 38,736 | 5.32M |
| 402 | LONA | LeonaBio, Inc. | 74.81M | 0.63% | 5,134 | - |
| 403 | ELTX | Elicio Therapeutics, Inc. | 74.64M | -5.33% | 421,556 | - |
| 404 | ANVS | Annovis Bio, Inc. | 73.28M | -4.97% | 504,513 | - |
| 405 | CRDF | Cardiff Oncology, Inc. | 73.13M | -4.67% | 528,695 | 508.00K |
| 406 | MNOV | MediciNova, Inc. | 70.63M | 1.06% | 16,884 | 920.48K |
| 407 | SPRO | Spero Therapeutics, Inc. | 69.88M | -0.83% | 312,779 | 47.00M |
| 408 | XBIT | XBiotech Inc. | 69.21M | -1.30% | 7,074 | - |
| 409 | PLRX | Pliant Therapeutics, Inc. | 68.73M | -3.48% | 233,137 | - |
| 410 | CSBR | Champions Oncology, Inc. | 68.50M | -1.79% | 5,139 | 59.43M |
| 411 | IBIO | iBio, Inc. | 67.56M | -2.86% | 521,248 | 100.00K |
| 412 | EXOZ | eXoZymes, Inc. | 66.53M | -0.17% | 2,781 | -700.00 |
| 413 | RNTX | Rein Therapeutics Inc. | 65.74M | -2.64% | 259,028 | - |
| 414 | HYFT | MindWalk Holdings Corp. | 65.31M | -2.11% | 73,601 | 11.43M |
| 415 | PMVP | PMV Pharmaceuticals, Inc. | 65.22M | -1.61% | 90,893 | - |
| 416 | INMB | INmune Bio Inc. | 64.67M | -2.92% | 215,132 | 50.00K |
| 417 | BOLD | Boundless Bio, Inc. | 64.37M | -1.05% | 75,518 | - |
| 418 | ALPS | Alps Group Inc | 64.05M | -6.12% | 61,706 | 3.74M |
| 419 | BSEM | BioStem Technologies, Inc. | 63.01M | -8.31% | 54,038 | 34.59M |
| 420 | SER | Serina Therapeutics, Inc. | 62.49M | -2.38% | 34,496 | 130.00K |
| 421 | EDSA | Edesa Biotech, Inc. | 62.42M | 0.43% | 70,556 | - |
| 422 | HRTX | Heron Therapeutics, Inc. | 62.01M | -1.66% | 953,134 | 151.18M |
| 423 | ELOX | Eloxx Pharmaceuticals, Inc. | 60.83M | -5.81% | 32,078 | - |
| 424 | IMA | ImageneBio, Inc. | 60.62M | 0.19% | 4,583 | 800.00K |
| 425 | XLO | Xilio Therapeutics, Inc. | 59.22M | -0.11% | 3,639 | 64.09M |
| 426 | APLM | Apollomics, Inc. | 58.41M | 1.14% | 6,329 | 8.84M |
| 427 | INKT | MiNK Therapeutics, Inc. | 58.32M | -2.16% | 3,860 | - |
| 428 | NTRB | Nutriband Inc. | 54.22M | -3.46% | 6,772 | 1.80M |
| 429 | ATYR | aTyr Pharma, Inc. | 52.97M | -2.63% | 266,253 | 190.00K |
| 430 | IMMP | Immutep Limited | 52.87M | 0.05% | 181,850 | 5.28M |
| 431 | TIL | Instil Bio, Inc. | 51.41M | -3.56% | 14,491 | - |
| 432 | TCRX | TScan Therapeutics, Inc. | 51.07M | 0.44% | 150,791 | 7.11M |
| 433 | MCRB | Seres Therapeutics, Inc. | 50.80M | 3.23% | 32,489 | 1.88M |
| 434 | HYPD | Hyperion DeFi, Inc. | 50.66M | -9.94% | 1,005,106 | 1.40M |
| 435 | IBO | Impact BioMedical Inc. | 47.84M | 0.61% | 6,730 | 35.00K |
| 436 | HOWL | Werewolf Therapeutics, Inc. | 45.84M | -2.83% | 2,333,849 | 21.00M |
| 437 | CELU | Celularity Inc. | 45.73M | -24.76% | 15,061,586 | 26.55M |
| 438 | MGX | Metagenomi Therapeutics, Inc. | 44.95M | -1.65% | 78,134 | 13.56M |
| 439 | FLNA | Filana Therapeutics, Inc. | 44.88M | 0.65% | 174,897 | - |
| 440 | TVGN | Tevogen Inc. | 44.86M | 2.07% | 2,625 | - |
| 441 | VERU | Veru Inc. | 44.76M | -4.20% | 92,787 | 16.89M |
| 442 | GRCE | Grace Therapeutics, Inc. | 44.60M | -1.85% | 66,072 | - |
| 443 | ALGS | Aligos Therapeutics, Inc. | 43.15M | -2.26% | 39,065 | 31.52M |
| 444 | KPTI | Karyopharm Therapeutics Inc. | 42.41M | -3.61% | 827,345 | 146.62M |
| 445 | MREO | Mereo BioPharma Group plc | 40.32M | -7.17% | 1,556,526 | 500.00K |
| 446 | ACTU | Actuate Therapeutics, Inc. | 39.74M | -2.07% | 231,245 | - |
| 447 | CRVO | CervoMed Inc. | 39.31M | -1.52% | 264,543 | 331.30K |
| 448 | RNAZ | TransCode Therapeutics, Inc. | 36.91M | -4.39% | 38,031 | - |
| 449 | CNTX | Context Therapeutics Inc. | 35.25M | -7.79% | 3,040,038 | - |
| 450 | QNCX | Quince Therapeutics, Inc. | 34.33M | 3.85% | 27,132 | - |
| 451 | VRXA | Veraxa Biotech AG | 34.04M | -6.25% | 315,715 | 29.54K |
| 452 | LITS | Lite Strategy, Inc. | 33.36M | -1.96% | 102,999 | - |
| 453 | KYNB | Kyntra Bio, Inc. | 32.47M | 0.25% | 15,783 | 4.62M |
| 454 | BCTX | BriaCell Therapeutics Corp. | 32.38M | 0.54% | 234,901 | - |
| 455 | IGC | IGC Pharma, Inc. | 32.05M | -7.16% | 878,170 | 1.11M |
| 456 | ATNM | Actinium Pharmaceuticals, Inc. | 31.76M | 1.00% | 112,015 | 35.09M |
| 457 | ESLA | Estrella Immunopharma, Inc. | 30.67M | -2.33% | 44,289 | - |
| 458 | BRNS | Barinthus Biotherapeutics plc | 30.49M | 2.07% | 31,317 | 14.97M |
| 459 | NNVC | NanoViricides, Inc. | 28.25M | -3.13% | 189,219 | - |
| 460 | GRDX | GridAI Technologies Corp. | 28.05M | -1.22% | 70,755 | - |
| 461 | RADX | Radiopharm Theranostics Limited | 28.01M | 6.64% | 334,030 | 8.74M |
| 462 | NXTC | NextCure, Inc. | 27.88M | 0.83% | 60,895 | - |
| 463 | CVM | CEL-SCI Corporation | 27.44M | -2.50% | 170,340 | - |
| 464 | BYSI | BeyondSpring Inc. | 27.36M | 3.94% | 114,241 | 1.88M |
| 465 | LTRN | Lantern Pharma Inc. | 26.46M | -4.17% | 91,730 | - |
| 466 | ATOS | Atossa Therapeutics, Inc. | 25.75M | -2.27% | 48,999 | - |
| 467 | EVAX | Evaxion A/S | 25.10M | -4.44% | 122,617 | 7.49M |
| 468 | QNTM | Quantum BioPharma Ltd. | 24.74M | -1.76% | 87,202 | - |
| 469 | PLRZ | Polyrizon Ltd. | 24.61M | 2.70% | 96,129 | - |
| 470 | TVRD | Tvardi Therapeutics, Inc. | 24.28M | 1.11% | 338,756 | - |
| 471 | CLRB | Cellectar Biosciences, Inc. | 23.91M | -0.39% | 23,820 | - |
| 472 | ENLV | Enlivex Ltd. | 23.61M | -8.47% | 531,296 | - |
| 473 | GNTA | Genenta Science S.p.A. | 23.59M | 0.94% | 58,845 | - |
| 474 | JSPR | Jasper Therapeutics, Inc. | 23.28M | 0.07% | 267,383 | - |
| 475 | CNSY | Cerenome, Inc. | 23.15M | -1.61% | 35,196 | 4.20M |
| 476 | MRKR | Marker Therapeutics, Inc. | 22.84M | -6.16% | 84,783 | 3.55M |
| 477 | ALLR | Allarity Therapeutics, Inc. | 22.43M | 2.17% | 139,927 | 345.00K |
| 478 | DYAI | Dyadic International, Inc. | 22.38M | -3.91% | 276,695 | 3.80M |
| 479 | ABVC | ABVC BioPharma, Inc. | 21.52M | 4.31% | 94,138 | 797.92K |
| 480 | LGVN | Longeveron Inc. | 21.42M | -1.18% | 79,507 | 1.19M |
| 481 | COCP | Cocrystal Pharma, Inc. | 21.19M | -3.51% | 28,740 | 330.00K |
| 482 | AKTX | Akari Therapeutics, Plc | 20.83M | 18.76% | 168,624 | - |
| 483 | NEUP | Neuphoria Therapeutics Inc. | 20.32M | -0.27% | 29,910 | -13.27K |
| 484 | NIKI | Niki BioSolutions, Inc. | 20.28M | -8.49% | 26,432 | - |
| 485 | CMMB | Chemomab Therapeutics Ltd. | 19.64M | -0.37% | 105,007 | - |
| 486 | KTTA | Pasithea Therapeutics Corp. | 18.71M | 0.99% | 483,905 | - |
| 487 | NCEL | NewcelX Ltd. | 18.43M | -6.73% | 12,435 | - |
| 488 | LPCN | Lipocine Inc. | 17.89M | -2.69% | 19,542 | 1.57M |
| 489 | CYCN | Cyclerion Therapeutics, Inc. | 17.46M | -5.01% | 59,759 | 1.90M |
| 490 | BCDA | BioCardia, Inc. | 17.41M | -1.71% | 159,256 | 3.00K |
| 491 | PTN | Palatin Technologies, Inc. | 17.33M | -0.10% | 129,102 | 12.88M |
| 492 | LEXX | Lexaria Bioscience Corp. | 17.10M | -11.39% | 61,906 | 194.00K |
| 493 | TPST | Tempest Therapeutics, Inc. | 16.94M | -1.85% | 63,978 | - |
| 494 | CTXR | Citius Pharmaceuticals, Inc. | 16.53M | -4.28% | 361,731 | 7.11M |
| 495 | PLUR | Pluri Inc. | 16.51M | - | 24,332 | 1.08M |
| 496 | BIVI | BioVie Inc. | 16.29M | -1.37% | 485,693 | - |
| 497 | PBM | Psyence Biomedical Ltd. | 16.06M | -2.32% | 16,078 | - |
| 498 | CALC | CalciMedica, Inc. | 15.86M | -1.19% | 676,016 | - |
| 499 | AEON | AEON Biopharma, Inc. | 15.67M | 6.91% | 1,113,951 | - |
| 500 | NRSN | NeuroSense Therapeutics Ltd. | 15.54M | -4.22% | 95,635 | - |